CardioDynamics International

CardioDynamics International was a medical technology company that specialized in the development and commercialization of non-invasive hemodynamic monitoring systems. The company's proprietary Impedance Cardiography (ICG) technology, marketed under the BioZ brand, allowed clinicians to measure cardiac output and other vital hemodynamic parameters without the risks associated with invasive procedures. These tools were primarily used to assist in the diagnosis and management of patients with hypertension, heart failure, and dyspnea. By providing real-time data on fluid status and cardiac function, CardioDynamics helped physicians optimize drug therapy and improve patient outcomes. In 2009, the company was acquired by SonoSite for approximately $10 million, integrating its technology into SonoSite's point-of-care diagnostic portfolio.